These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16700851)

  • 1. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
    Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
    Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
    Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
    Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
    Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
    Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L
    Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
    Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
    Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
    Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A; Hunt R
    Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
    Wolfe F; Hawley DJ
    J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
    Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
    Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.